Back to results
US 2003/0194446 A1Published application
Zinc oxide compositions for dermatheraputics
OwnerLindy K. Akes, Michael E. Cournoyerinventors
Life of this patent
Estimating the term…
Abstract
20% Zinc oxide formulations including up to 5% of at least one pharmacologically active agent and associated topical methods for improved therapeutic treatment of adverse atopic dermatological conditions.
Claims15
A topical therapueutic composition, comprising:
- 20% zinc oxide;
- 0.025-5% of a therapueutucally active agent selected from the group consisting of adrenocortical steroids, Polymyxin B Sulfate, Bacitracin Zinc and Neomycin, Quinoline, Betamethasone dipropionate, Pramoxime hydrochloride, Clotrimazole, and Ketoconazole;
- and
- a base comprising a mixture of at least two compounds selected from the group consisting of petrolatum, wax, mineral oil, and lanolin.
1 more element
Dependencies are inferred from the claim text.